Lateral and axial measurement differences between spectral-domain optical coherence tomography systems

Abstract. We assessed the reproducibility of lateral and axial measurements performed with spectral-domain optical coherence tomography (SDOCT) instruments from a single manufacturer and across several manufacturers. One human retina phantom was imaged on two instruments each from four SDOCT platforms: Zeiss Cirrus, Heidelberg Spectralis, Bioptigen SDOIS, and hand-held Bioptigen Envisu. Built-in software calipers were used to perform manual measurements of a fixed lateral width (LW), central foveal thickness (CFT), and parafoveal thickness (PFT) 1 mm from foveal center. Inter- and intraplatform reproducibilities were assessed with analysis of variance and Tukey-Kramer tests. The range of measurements between platforms was 5171 to 5290 μm for mean LW (p<0.001), 162 to 196 μm for mean CFT (p<0.001), and 267 to 316 μm for mean PFT (p<0.001). All SDOCT platforms had significant differences between each other for all measurements, except LW between Bioptigen SDOIS and Envisu (p=0.27). Intraplatform differences were significantly smaller than interplatform differences for LW (p=0.020), CFT (p=0.045), and PFT (p=0.004). Conversion factors were generated for lateral and axial scaling between SDOCT platforms. Lateral and axial manual measurements have greater variance across different SDOCT platforms than between instruments from the same platform. Conversion factors for measurements from different platforms can produce normalized values for patient care and clinical studies.

[1]  Ton G van Leeuwen,et al.  Comparison of retinal nerve fiber layer thickness measurements by spectral‐domain optical coherence tomography systems using a phantom eye model , 2013, Journal of biophotonics.

[2]  Joseph A Izatt,et al.  Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. , 2010, Investigative ophthalmology & visual science.

[3]  G. Ying,et al.  Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. , 2012, Ophthalmology.

[4]  Joseph Vance,et al.  Spectral-domain optical coherence tomography as a noninvasive method to assess damaged and regenerating adult zebrafish retinas. , 2012, Investigative ophthalmology & visual science.

[5]  J. Duker,et al.  COMPARISON OF SPECTRAL/FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY INSTRUMENTS FOR ASSESSMENT OF NORMAL MACULAR THICKNESS , 2010, Retina.

[6]  L. Pierro,et al.  Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments. , 2010, American journal of ophthalmology.

[7]  Andreas Wenzel,et al.  Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography , 2009, PloS one.

[8]  Adam M. Dubis,et al.  Assessing Errors Inherent in OCT-Derived Macular Thickness Maps , 2011, Journal of ophthalmology.

[9]  Zvia Burgansky-Eliash,et al.  Inter-device variability of the Stratus optical coherence tomography. , 2009, American journal of ophthalmology.

[10]  Eric L Yuan,et al.  Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. , 2014, Ophthalmology.

[11]  Cynthia A Toth,et al.  Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. , 2013, Ophthalmology.

[12]  Ian C. Han,et al.  Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. , 2009, American journal of ophthalmology.

[13]  Shutao Li,et al.  Fast Acquisition and Reconstruction of Optical Coherence Tomography Images via Sparse Representation , 2013, IEEE Transactions on Medical Imaging.

[14]  Usha Chakravarthy,et al.  Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. , 2012, Ophthalmology.

[15]  Lala Ceklic,et al.  Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. , 2009, Investigative ophthalmology & visual science.

[16]  Susanne Binder,et al.  Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. , 2010, Ophthalmology.

[17]  Sina Farsiu,et al.  Dynamics of human foveal development after premature birth. , 2011, Ophthalmology.

[18]  Hiroshi Ishikawa,et al.  Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice. , 2010, Investigative ophthalmology & visual science.

[19]  Sina Farsiu,et al.  Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. , 2012, American journal of ophthalmology.

[20]  Bernd Hamann,et al.  Toward building an anatomically correct solid eye model with volumetric representation of retinal morphology , 2010, BiOS.

[21]  Sina Farsiu,et al.  Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. , 2012, Archives of ophthalmology.

[22]  G. Wollstein,et al.  Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. , 2004, Investigative ophthalmology & visual science.

[23]  Srinivas R Sadda,et al.  Impact of scanning density on measurements from spectral domain optical coherence tomography. , 2010, Investigative ophthalmology & visual science.

[24]  Joseph Carroll,et al.  Evaluation of normal human foveal development using optical coherence tomography and histologic examination. , 2012, Archives of ophthalmology.

[25]  Susanne Binder,et al.  REPRODUCIBILITY AND COMPARISON OF RETINAL THICKNESS AND VOLUME MEASUREMENTS IN NORMAL EYES DETERMINED WITH TWO DIFFERENT CIRRUS OCT SCANNING PROTOCOLS , 2011, Retina.

[26]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.